Not yet, but they will soon be.....make it easy to write, give it a fair price, take the time and get it covered on formulary.....let Amgen work out the bugs for us.....recipe for a big roll out in Primary Care where the migraine issues first show up. Sounds logical to me. Two sales forces at Lilly selling as a team vs. Amgen and Novartis fighting over who is the better company (good luck with that). Amgen/Novartis you might be first to market.....but first to market usually means finishing 2nd or 3rd as a commercial success in the years to come. Time to move over and let us show you how to roll out and successfully launch a migraine med. You only get one chance to make a first impression! Time will tell but I'm putting my money on Lilly!